BKYI
BIO-key International, Inc.NASDAQIndustrials$0.55+1.69%ClosedMarket Cap: $3.7M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.67
P/S
0.60
EV/EBITDA
-0.25
DCF Value
$-23.46
FCF Yield
-127.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
77.5%
Operating Margin
-69.9%
Net Margin
-75.3%
ROE
-65.4%
ROA
-42.2%
ROIC
-54.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.2M | 78.1% | $-1.6M | $-1.7M | $-0.19 | — |
| FY 2025 | $6.1M | 77.5% | $-4.3M | $-4.6M | $-0.69 | — |
| Q3 2025 | $1.5M | 76.9% | $-892.2K | $-964.8K | $-0.15 | — |
| Q2 2025 | $1.7M | 72.6% | $-1.1M | $-1.2M | $-0.20 | — |
| Q1 2025 | $1.6M | 82.6% | $-640.6K | $-736.5K | $-0.16 | — |
| Q4 2024 | $1.5M | 82.1% | $-1.3M | $-1.6M | $-0.52 | — |
| FY 2024 | $6.9M | 81.4% | $-4.0M | $-4.3M | $-1.11 | — |
| Q3 2024 | $2.1M | 78.3% | $-580.4K | $-739.0K | $-0.39 | — |
| Q2 2024 | $1.1M | 77.0% | $-1.7M | $-1.7M | $-1.00 | — |
| Q1 2024 | $2.2M | 86.3% | $-508.9K | $-510.3K | $-0.32 | — |
| Q4 2023 | $925.1K | -377.9% | $-6.5M | $-6.2M | $-5.67 | — |
| FY 2023 | $7.8M | 18.5% | $-8.8M | $-8.5M | $-15.21 | — |